Л. А. Щепанкевич

2 ta ish

Federal Research Center for Fundamental and Translational Medicine, Novosibirsk, Russia

1. Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)

   Fedin Ai, В. В. Захаров, M. М. Tanashyan +4

   MaqolaNeurological Disorders and TreatmentsS S Korsakov Journal of Neurology and Psychiatry20212 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.000049

2. New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council

   A B Danilov, А. М. Лила, Yo. N. Majidova +32

   MaqolaMusculoskeletal pain and rehabilitationNeurology neuropsychiatry Psychosomatics20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.001983